| Andrew Charles Crider, AA | |
|
460 Lanier Rd, Madison, AL 35758-1866 | |
| (256) 319-9000 | |
| Not Available |
| Full Name | Andrew Charles Crider |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology Assistant |
| Experience | 31 Years |
| Location | 460 Lanier Rd, Madison, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891750584 | NPI | - | NPPES |
| 051555185 | Medicaid | AL | |
| 51524120 | Other | AL | BCBS ALABAMA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | AA813 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Crestwood Medical Center | Huntsville, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Physynergy Llc | 6204081292 | 64 |
News Archive
Health Evolution Partners, a manager of healthcare investment funds, announced today that its portfolio company, CambridgeSoft, has entered into a definitive agreement to be acquired by PerkinElmer, Inc.
The University of California, Riverside Bridges to the Baccalaureate Program has received the 2018 Inspiring Programs in STEM Award from INSIGHT Into Diversity magazine, the largest and oldest publication in higher education addressing diversity and inclusion.
Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced the start of a U.S. Phase I clinical trial of its biosimilar erythropoietin (EPO) in patients with renal (kidney) dysfunction who have anemia, an important step on the road toward introducing a biosimilar product in the United States. Erythropoietin is a treatment for anemia associated with chronic renal failure and chemotherapy.
A report from the nation's leading cancer organizations shows rates of death in the United States from all cancers for men and women continued to decline between 2003 and 2007. The findings come from the latest Annual Report to the Nation on the Status of Cancer.
Rehabilitation is recommended for many patients following a hospital stay for acute heart disease. In a recent original article in Deutsches Ärzteblatt International (Dtsch Arztebl int 112: 527-34) Axel Schlitt et al. show that this improves prognosis for heart disease and can thus reduce patient mortality.
› Verified 5 days ago
| Entity Name | Physynergy Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134465560 PECOS PAC ID: 6204081292 Enrollment ID: O20130222000456 |
News Archive
Health Evolution Partners, a manager of healthcare investment funds, announced today that its portfolio company, CambridgeSoft, has entered into a definitive agreement to be acquired by PerkinElmer, Inc.
The University of California, Riverside Bridges to the Baccalaureate Program has received the 2018 Inspiring Programs in STEM Award from INSIGHT Into Diversity magazine, the largest and oldest publication in higher education addressing diversity and inclusion.
Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced the start of a U.S. Phase I clinical trial of its biosimilar erythropoietin (EPO) in patients with renal (kidney) dysfunction who have anemia, an important step on the road toward introducing a biosimilar product in the United States. Erythropoietin is a treatment for anemia associated with chronic renal failure and chemotherapy.
A report from the nation's leading cancer organizations shows rates of death in the United States from all cancers for men and women continued to decline between 2003 and 2007. The findings come from the latest Annual Report to the Nation on the Status of Cancer.
Rehabilitation is recommended for many patients following a hospital stay for acute heart disease. In a recent original article in Deutsches Ärzteblatt International (Dtsch Arztebl int 112: 527-34) Axel Schlitt et al. show that this improves prognosis for heart disease and can thus reduce patient mortality.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrew Charles Crider, AA 2006 Franklin St Se, Suite 301, Huntsville, AL 35801-4551 Ph: (256) 539-9471 | Andrew Charles Crider, AA 460 Lanier Rd, Madison, AL 35758-1866 Ph: (256) 319-9000 |
News Archive
Health Evolution Partners, a manager of healthcare investment funds, announced today that its portfolio company, CambridgeSoft, has entered into a definitive agreement to be acquired by PerkinElmer, Inc.
The University of California, Riverside Bridges to the Baccalaureate Program has received the 2018 Inspiring Programs in STEM Award from INSIGHT Into Diversity magazine, the largest and oldest publication in higher education addressing diversity and inclusion.
Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced the start of a U.S. Phase I clinical trial of its biosimilar erythropoietin (EPO) in patients with renal (kidney) dysfunction who have anemia, an important step on the road toward introducing a biosimilar product in the United States. Erythropoietin is a treatment for anemia associated with chronic renal failure and chemotherapy.
A report from the nation's leading cancer organizations shows rates of death in the United States from all cancers for men and women continued to decline between 2003 and 2007. The findings come from the latest Annual Report to the Nation on the Status of Cancer.
Rehabilitation is recommended for many patients following a hospital stay for acute heart disease. In a recent original article in Deutsches Ärzteblatt International (Dtsch Arztebl int 112: 527-34) Axel Schlitt et al. show that this improves prognosis for heart disease and can thus reduce patient mortality.
› Verified 5 days ago
Mark Isaac Copeland, A.A. Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 460 Lanier Rd, Madison, AL 35758 Phone: 256-319-9000 | |
Michael Hamilton Fleming, A.A. Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 460 Lanier Rd, Madison, AL 35758 Phone: 256-319-9000 |